|1.||Lang, Florian: 10 articles (02/2014 - 01/2006)|
|2.||Vallon, Volker: 5 articles (02/2012 - 01/2006)|
|3.||Charmandari, Evangelia: 4 articles (06/2014 - 05/2002)|
|4.||Sasano, Hironobu: 3 articles (10/2015 - 01/2003)|
|5.||Arlt, W: 3 articles (08/2014 - 11/2000)|
|6.||Artunc, Ferruh: 3 articles (01/2014 - 01/2006)|
|7.||Arlt, Wiebke: 3 articles (03/2012 - 04/2009)|
|8.||Hindmarsh, Peter C: 3 articles (01/2010 - 05/2002)|
|9.||Görlach, Agnes: 3 articles (01/2010 - 05/2006)|
|10.||Kempton, J Beth: 3 articles (05/2009 - 11/2008)|
|1.||Hypertension (High Blood Pressure)
08/01/1995 - "The aim of this study is to determine whether mineralocorticoids, which are known to be involved in the pathogenesis of hypertension, can influence the atherosclerotic process in Watanabe heritable hyperlipidemic rabbits (WHHL) independently of pressure changes. "
11/01/1994 - "The aim of this study was to determine whether mineralocorticoids, which are known to be involved in the pathogenesis of hypertension, could be implicated in the atherosclerotic process independent of pressure changes. "
07/01/1983 - "Data from clinical and experimental studies indicate that mechanism(s) for action of mineralocorticoids, other than renal, must be involved in the overall effect of mineralocorticoids on circulation--increased peripheral resistance and hypertension. "
01/01/1982 - "Data from clinical and experimental studies indicate that mechanism(s) for action of mineralocorticoids, other than renal, must be involved in the overall effect of mineralocorticoids on circulation--increased peripheral resistance and hypertension. "
10/01/1981 - "Studies on the mechanism of mineralocorticoid-induced hypertension: evidence for the presence of an in-situ mechanism in the arterial wall for a direct action of mineralocorticoids."
05/24/1997 - "Recent advances in genetics has improved our knowledge of the pathophysiological mechanisms involved in certain rare diseases including apparent overproduction of mineralocorticoids, Liddle syndrome and Gitelman syndrome, and to hypothesize on the mechanism of primary hypertension. "
12/01/2001 - "A major focus of these studies has been the epithelial sodium channel (ENaC), which can be directly affected by mutations (eg, Liddle syndrome, autosomal recessive pseudohypoaldosteronism, type I) or by changes in the response to (autosomal recessive pseudohypoaldosteronism, type I), or production of mineralocorticoids (apparent mineralocorticoid excess syndrome, glucocorticoid-remediable aldosteronism). "
04/01/1999 - "A major focus of these studies has been the epithelial sodium channel (ENaC), which can be directly affected by mutations (eg, Liddle syndrome, autosomal recessive pseudohypoaldosteronism, type I) or by changes in the response to (autosomal recessive pseudohypoaldosteronism, type I), or production of mineralocorticoids (apparent mineralocorticoid excess syndrome, glucocorticoid-remediable aldosteronism). "
|3.||Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/01/2011 - "Replacement therapy with gluco-and mineralocorticoids is life-saving for patients with chronic adrenal insufficiency."
01/01/1998 - "Adrenal insufficiency is well controlled by gluco- and mineralocorticoids. "
01/01/1983 - "It is being suggested that the changes of PRC, RRA and RSC observed up to the 10th post-enucleation day indicates relative adrenal insufficiency, the shorter duration of which in immature rats reflects their higher sensitivity to mineralocorticoids produced by the regenerating adrenal. "
09/01/1970 - "These studies strongly suggest (a) that ADH is not essential to the inhibition of an acute water diuresis in adrenal insufficiency, although it may abet the inhibition in individuals without diabetes insipidus, which can elaborate ADH; and (b) that both gluco- and mineralocorticoids are required in adrenal insufficiency in order to fully restore the water diuresis as judged by the dual criteria of urine flow and urine osmolality."
07/01/2014 - "We report a case of a 22-year-old male with AMN who developed adrenal insufficiency at the age of 4 years successfully treated by gluco- and mineralocorticoids followed by features of myeloneuropathy with bulbar palsy. "
|4.||Hearing Loss (Hearing Impairment)
03/01/2015 - "[A comparative study on efficacy of glucocorticoids, mineralocorticoids and vasoactive drugs on reversing hearing loss in patients suffering idiopathic sensorineural cochlear hypoacusis. "
01/01/2009 - "Previous studies of steroid-responsive hearing loss in autoimmune (lupus) mice showed glucocorticoids and mineralocorticoids were equally effective, suggesting the ion homeostasis functions of glucocorticoids may be as relevant as immunosuppression for control of autoimmune-induced inner ear disease. "
07/01/1995 - "Mineralocorticoids, which suppress natriuresis, are safe and effective in the treatment of hyponatremia of central origin. "
01/01/2015 - "We can therefore conclude that mineralocorticoids may be used to correct hyponatremia in SCLC patients when appropriate. "
02/01/2003 - "The Authors report two cases of APECED syndrome (Auto-immune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy) revealed by hyponatremia due to isolated mineralocorticoids deficiency. "
06/01/2013 - "Potential treatments for hyponatremia include mineralocorticoids and vasopressin 2 receptor antagonists, but further work is required to validate their usage. "
01/01/1996 - "We have shown that severe hyponatremia that occurs with combined deficiency of glucocorticoids and mineralocorticoids can be corrected with high salt intake and glucocorticoid replacement without correcting mineralocorticoid deficiency."
|3.||Adrenal Cortex Hormones (Corticosteroids)
|4.||Steroid Receptors (Steroid Receptor)
|5.||Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)
|8.||Ion Exchange Resins
|10.||Epithelial Sodium Channel
|3.||Infusion Pumps (Infusion Pump)
|4.||Renal Dialysis (Hemodialysis)